Why did DoorDash acquire Deliveroo?
How will Trump’s movie tariffs impact Hollywood?
What caused delays at Newark Liberty International Airport?
Why did Ford suspend its 2025 financial guidance?
How will tariffs affect Mattel’s toy prices?
What does Warren Buffett’s retirement mean for Berkshire?
Why is OpenAI reversing its for-profit plans?
How are Trump’s tariffs influencing US trade deficits?
What’s behind Palantir’s recent stock decline?
MIRA Pharmaceuticals Lead Program Ketamir-2 Shows No Brain Toxicity In FDA-Mandated Study
benzinga.com/general/biotech/25/05/45217506/exclusive-mira-pharmaceuticals-lead-program-ketamir-2-shows-no-brain-toxicity-in-fda-mandated-stu
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) released results from a neurotoxicity study of Ketamir-2, its novel oral NMDA receptor antagonist, on Tuesday.
The U.S. Food and Drug Administration (FDA) required the study before initiating human dosing in the United States.
The preclinical…
This story appeared on benzinga.com, 2025-05-06 11:16:43.